HIV/AIDS Therapy
Research from University of Texas, Department of Internal Medicine in HIV/AIDS therapy provides new insights
Published in Hepatitis Weekly, April 16th, 2007
New research, "Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response," is the subject of a report. According to a study from the United States, "As therapy for human immunodeficiency virus (HIV) infection evolves, optimizing hepatitis B virus (HBV) treatment and identifying factors that impact its response in the HIV/HBV-coinfected population is critical. We identified retrospectively 45 HBV/HIV-coinfected patients with detectable HBV DNA by the Bayer VERSANT HBV 3.0 bDNA assay (limit of quantification 2000 copies/mL) at baseline and/or year 1 of therapy."
"Patients were divided into three groups based on...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-04-16)
More Articles from Hepatitis Weekly
- Hepatitis A Virus
FDA Approves Accelerated Dosing Schedule for GlaxoSmithKline's Twinrix - B-Cell Lymphoma Therapy
Research on B-cell lymphoma therapy described by scientists at University of Pavia, Division of Hematology - Cancer Vaccines
Findings from Temple University in cancer vaccines reported - Gene Therapy
Recent studies from University of Connecticut, Health Center add new data to gene therapy - Hepatitis A Virus
Reports from Tan Tock Seng Hospital, Department of Infectious Diseases add new data to research in hepatitis A virus - Hepatitis B Virus
Data from Scripps Research Institute advance knowledge in hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
